US5070884A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Needle device for safely collecting blood or injecting drugs
Assignee: Clinical Diagnostic Systems Inc
•
Filing: 1990-02-20
•
Granted: 1991-12-10
•
Expires: 2010-02-20
Abstract
Abstract A needle device and method of use are disclosed, wherein the needle moves out of and into a protective housing, between two operative positions, one of which causes the housing to shield the needle. Each operative position includes releasable locking detents to temporarily hold the needle in one of those positions, the holding force of one being less than the other. A third position beyond the one that shields the needle in the housing is used to permanently lock the needle in the housing against accidental reuse. The needle device can be used with a blood collection container or a syringe drug delivery container, each one releasably mating with the device during use.
Inventors
- 👤 Richard L. Columbus
- 👤 Johannes J. Porte
- 👤 Harvey J. Palmer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 03:52
CPC Classifications
B; B01; B01L; B01L3/00; B01L3/50; B01L3/502; B01L3/5021; A; A61; A61B; A61B5/00; A61B5/15; A61B5/150007; A61B5/150015; A61B5/15003; A61B5/150206; A61B5/150213; A61B5/150221; A61B5/150351; A61B5/150374; A61B5/150534; A61B5/150633; A61B5/150641; A61B5/150732; A61B5/150748; A61B5/150755; A61B5/150885; A61B5/150893; A61B5/150916; A61B5/153; A61B5/154; A61M; A61M5/00; A61M5/178; A61M5/31; A61M5/32; A61M5/3205; A61M5/321; A61M5/3243; A61M5/3271; A61B5/150381; A61B5/150389; A61B5/150473; A61B5/150572; A61M5/322; A61M5/3221; A61M2005/3228; A61M5/3272; A61M5/50; A61M5/5086
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
220 words
A method of collecting whole blood and separating serum from the cells of the blood, comprising inserting a phlebotomy tube into a needle mount having a protective sheath slidable thereover, sliding said needle mount within said protective sheath until a) said needle extends out of said sheath and b) said needle has penetrated said tube, collecting blood in said tube, said tube including as composite parts thereof, a first chamber for receiving and separating the liquid into at least two phases by spinning the chamber about an axis external to said chamber, said chamber including means for maintaining said phase separation after spinning, a second chamber for collecting the lighter of said at least two phases from said first chamber, said second chamber including a first aperture for recovering said lighter phase from said first chamber and a valve means for controlling the flow of liquid from said first chamber to said second chamber in response to hydrostatic pressure; removing said tube from said needle, spinning said tube in a centrifuge until the heavier cell phase is separated from the lighter serum phase, and removing said lighter phase into said second chamber by increasing the spinning forces sufficiently above the speed used to separate the phases to force said valve to open due to an increased hydrostatic head of pressure.
Claim 2
Independent Claim
220 words
A method of collecting whole blood and separating serum from the cells of the blood, comprising inserting a phlebotomy tube into a needle mount having a protective sheath slidable thereover, sliding said needle mount within said protective sheath until a) said needle extends out of said sheath and b) said needle has penetrated said tube, collecting blood in said tube, said tube including as composite parts thereof, a first chamber for receiving and separating the liquid into at least two phases by spinning the chamber about an axis external to said chamber, said chamber including means for maintaining said phase separation after spinning, a second chamber for collecting the lighter of said at least two phases from said first chamber, said second chamber including a first aperture for recovering said lighter phase from said first chamber and a valve means for controlling the flow of liquid from said first chamber to said second chamber in response to hydrostatic pressure; removing said tube from said needle, spinning said tube in a centrifuge until the heavier cell phase is separated from the lighter serum phase, and removing said lighter phase into said second chamber by increasing the spinning forces sufficiently above the speed used to separate the phases to force said valve to open due to an increased hydrostatic head of pressure.
References Cited (Backward Citations)
US4425120A
Cited
US4492634A
Cited
US4879098A
Cited
US4664259A
Cited
US4631057A
Cited
US4801295A
Cited
EP0254246A2
Cited
US4737144A
Cited
US4915702A
Cited
US4850374A
Cited
US4892107A
Cited
US4871355A
Cited
US4957637A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-12-09 | 1995-06-10 | 1995-12-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-12-09 | 1999-06-10 | 1999-12-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-12-09 | 2003-06-10 | 2003-12-10 | $7700.00 | Window Closed / Lapsed |